86 related articles for article (PubMed ID: 37459679)
1. Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges.
Cui M; Lemmon K; Jin Z; Uboha NV
Pathol Res Pract; 2023 Aug; 248():154692. PubMed ID: 37459679
[TBL] [Abstract][Full Text] [Related]
2. Undifferentiated Carcinoma of Esophagus with SMARCA4 Deletion Expressing Synaptophysin: A Potential Diagnostic Pitfall.
Cui M; Uboha N
Int J Surg Pathol; 2024 Apr; 32(2):356-358. PubMed ID: 37143312
[TBL] [Abstract][Full Text] [Related]
3. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
4. SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.
Neil AJ; Zhao L; Isidro RA; Srivastava A; Cleary JM; Dong F
Mod Pathol; 2023 Jun; 36(6):100183. PubMed ID: 37054973
[TBL] [Abstract][Full Text] [Related]
5. A Subset of Thoracic SMARCA4-Deficient Undifferentiated Tumors Express GATA3.
Coconubo DM; Wangsiricharoen S; Pettus JR; Linos K; Pinto A; Wang WL; Kerr DA; Cloutier JM
Int J Surg Pathol; 2024 Jun; 32(4):684-691. PubMed ID: 37461275
[TBL] [Abstract][Full Text] [Related]
6. Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
PeerJ; 2024; 12():e16923. PubMed ID: 38374950
[TBL] [Abstract][Full Text] [Related]
7. Under the Microscope: A Case Report of Thoracic SMARCA4-Deficient Undifferentiated Tumor with Review of the Literature.
Mundada M; Mannan KA; Vasu D; Ahmed F; K S
Turk Patoloji Derg; 2024; 40(2):128-133. PubMed ID: 38265099
[TBL] [Abstract][Full Text] [Related]
8. Primary Oropharyngeal SMARCA4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in Head and Neck Cancer.
Pasricha S; Goyal S; Kamboj M; Diwan H; Gairola M; Sethi JS; Gupta M; Mehta A
Head Neck Pathol; 2024 Mar; 18(1):16. PubMed ID: 38457069
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].
Han J; Gao XZ; Xu Y; Liu EJ; Du Q; Chen K; Li SL
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):136-142. PubMed ID: 38281780
[No Abstract] [Full Text] [Related]
10. Esophageal carcinoma with
Xu J; Chi Z
Transl Gastroenterol Hepatol; 2024; 9():24. PubMed ID: 38716209
[TBL] [Abstract][Full Text] [Related]
11. SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.
Ehrenhöfer-Wölfer K; Puchner T; Schwarz C; Rippka J; Blaha-Ostermann S; Strobl U; Hörmann A; Bader G; Kornigg S; Zahn S; Sommergruber W; Schweifer N; Zichner T; Schlattl A; Neumüller RA; Shi J; Vakoc CR; Kögl M; Petronczki M; Kraut N; Pearson MA; Wöhrle S
Sci Rep; 2019 Aug; 9(1):11661. PubMed ID: 31406271
[TBL] [Abstract][Full Text] [Related]
12. Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.
Shi M; Pang L; Zhou H; Mo S; Sheng J; Zhang Y; Liu J; Sun D; Gong L; Wang J; Zhuang W; Huang Y; Chen Z; Zhao Y; Li J; Huang Y; Yang Y; Fang W; Zhang L
Lung Cancer; 2024 Jun; 192():107818. PubMed ID: 38763102
[TBL] [Abstract][Full Text] [Related]
13. Germline pathogenic
Witkowski L; Nichols KE; Jongmans M; van Engelen N; de Krijger RR; Herrera-Mullar J; Tytgat L; Bahrami A; Mar Fan H; Davidson AL; Robertson T; Anderson M; Hasselblatt M; Plon SE; Foulkes WD
J Med Genet; 2023 Oct; 60(10):987-992. PubMed ID: 36813544
[TBL] [Abstract][Full Text] [Related]
14. SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas.
Panozzi M; Alì G; Proietti A; Melfi F; Zirafa CC; Lucchi M; Fontanini G
Pathologica; 2023 Jun; 115(3):164-171. PubMed ID: 37387441
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasm: A rare case report and literature review.
Gumusgoz E; Graham BS; Hosler GA
J Cutan Pathol; 2024 Apr; 51(4):262-266. PubMed ID: 38124373
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
Wang J; Elghawy O; Kurpiel B; Kaur V
Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
[TBL] [Abstract][Full Text] [Related]
17. NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts and controversies.
Yoshida A
Histopathology; 2024 Jan; 84(1):86-101. PubMed ID: 37873676
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
Longo V; Catino A; Montrone M; Montagna ES; Pesola F; Marech I; Pizzutilo P; Nardone A; Perrone A; Gesualdo M; Galetta D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542211
[TBL] [Abstract][Full Text] [Related]
19. Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives.
Shinno Y; Ohe Y;
Jpn J Clin Oncol; 2024 Mar; 54(3):265-270. PubMed ID: 38117955
[TBL] [Abstract][Full Text] [Related]
20. Identification and Treatment of SMARCA4 Deficient Poorly Differentiated Gastric Carcinoma.
Bhat V; Koneru M; Knapp K; Joneja U; Morrison J; Hong YK
Am Surg; 2023 Nov; 89(11):4987-4989. PubMed ID: 36533880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
